-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

703. Cellular Immunotherapies: Basic and Translational: Poster II

Symposia: Cellular Immunotherapies: Basic and Translational Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 11, 2022: 6:00 PM-8:00 PM
Hall D (Ernest N. Morial Convention Center)

Wannakorn Khopanlert, MD1,2*, Pongsakorn Choochuen, MD1,3*, Nawaphat Jangphattananont, PhD2*, Kajornkiat Maneechai, BSc1,2*, Socheatraksmey Ung, PharmB1,2*, Surasak Sangkhathat, MD, PhD3*, Pongtep Viboonjuntra, MD, PhD2*, Seitaro Terakura, MD, PhD4* and Jakrawadee Julamanee, MD, PhD2*

1Department of Biomedical Sciences and Biomedical Engineering, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand
2Stem Cell Laboratory, Hematology Unit, Division of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand
3Translational Medicine Research Center, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand
4Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan

Lorea Jordana-Urriza, BSc1,2*, Guillermo Serrano, BSc2,3*, Maria Erendira Calleja-Cervantes, PhD1,2,3*, Patxi San Martin-Uriz, PhD1,2*, Amaia Vilas-Zornoza, PhD1,2,4*, Asier Ullate-Agote, PhD1,2*, Aintzane Zabaleta, PhD1,2,4,5*, Diego Alignani, PhD1,2,4*, Teresa Lozano, PhD2,6*, Valentin Cabañas, MD7*, Almudena Navarro-Bailón8*, Aina Oliver-Caldes, MD9*, Marta Español-Rego10*, Mariona Pascal10*, Manel Juan, MD, PhD10,11*, Álvaro Urbano-Ispizua, MD, PhD9, Juan Luis Reguera, MD12*, Jose Maria Moraleda, MD, PhD7,11*, Maria-Victoria Mateos, MD4,8, Fermin Sanchez-Guijo, MD, PhD4,8,11*, Ana Alfonso Pierola, MD2,4,13*, José J. Rifón Roca, M.D.2,4,13*, Paula Rodríguez-Otero, MD, PhD2,4,13*, Carlos Fernandez de Larrea, MD9, Bruno Paiva1,2,4,5*, Susana Inogés, MD, PhD2,4,13,14*, Ascensión López-Diaz de Cerio, PhD2,4,13,14*, Juan Jose Lasarte, PhD2,6,15*, Jesús San-Miguel, MD, PhD1,2,4,13,15, Juan Roberto Rodriguez-Madoz, PhD1,2,4*, Mikel Hernáez, PhD2,3,4,16* and Felipe Prósper, MD, PhD1,2,4,11,13,15*

1Hemato-Oncology Program, Cima Universidad de Navarra, Pamplona, Spain
2Navarra Institute for Health Research (IdiSNA), Pamplona, Spain
3Computational Biology Program, Cima Universidad de Navarra, Pamplona, Spain
4Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain
5Flow Cytometry Core, Cima Universidad de Navarra, Pamplona, Spain
6Immunology and Immunotherapy Program, Cima Universidad de Navarra, Pamplona, Spain
7Department of Hematology, IMIB-Virgen de la Arrixaca University Hospital. University of Murcia, Murcia, Spain
8Hematology Department, IBSAL-University Hospital of Salamanca. University of Salamanca, Salamanca, Spain
9Department of Hematology, Hospital Clínic de Barcelona. IDIBAPS. University of Barcelona, Barcelona, Spain
10Department of Immunology, Hospital Clínic de Barcelona. IDIBAPS. University of Barcelona, Barcelona, Spain
11Red RICORS TERAV, Madrid, Spain
12Department of Hematology, University Hospital Virgen del Rocio-IBIS. Universidad de Sevilla, Sevilla, Spain
13Hematology and Cell Therapy Department, Clínica Universidad de Navarra, Pamplona, Spain
14Immunology and Immunotherapy Department, Clínica Universidad de Navarra, Pamplona, Spain
15Cancer Center Universidad de Navarra (CCUN), Pamplona, Spain
16Data Science and Artificial Intelligence Institute (DATAI). Universidad de Navarra, Pamplona, Spain

Simona Caruso, PhD1*, Concetta Quintarelli, PhD2,3*, Biagio De Angelis, PhD1*, Francesca Del Bufalo, MD4*, Roselia Ciccone5*, Samantha Donsante, PhD6*, Gabriele Volpe7*, Simona Manni, PhD8*, Marika Guercio1*, Michele Pezzella, PhD9*, Laura Iaffaldano, PhD9*, Domenico Alessandro Silvestris, PhD9*, Matilde Sinibaldi, PhD10*, Stefano Di Cecca, PhD10*, Angela Pitisci4*, Enrico Velardi, PhD4*, Pietro Merli, MD11*, Mattia Algeri, MD12*, Mariachiara Lodi, MD9*, Valeria Paganelli, MD9*, Marta Serafini, PhD13*, Mara Riminucci14* and Franco Locatelli, Prof., MD, PhD4,15

1Department of Hematology/Oncology and Cell and Gene Therapy, IRCCS Bambino Gesù Children’s Hospital, Rome, Italy
2Department of Onco-Haematology and Cell and Gene Therapy, Bambino Gesù Children's Hospital, Rome, Italy
3Department of Clinical Medicine and Surgery, Federico II University of Naples, Naples, Italy
4Department of Pediatric Hematology/Oncology, Cell and Gene Therapy, IRCCS Bambino Gesù Children's Hospital, Rome, Italy
5Department of Oncology/Haematology, Cell and Gene Therapy, Bambino Gesù Children's Hospital, Rome, ITA
6Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy
7Research Laboratories, IRCCS Bambino Gesù Children's Hospital, Rome, Italy
8Department of Oncology-Haematology, and Cell and Gene Therapy, Bambino Gesù Children Hospital, Roma, ITA
9Department of Oncology/Haematology, Cell and Gene Therapy, Bambino Gesù Children's Hospital, Rome, Italy
10Department of Hematology/Oncology, Cell and Gene Therapy, Bambino Gesù Children’s Hospital, Rome, Italy
11Department of Pediatric Hematology/Oncology, Cell and Gene Therapy, IRRCS Ospedale Pediatrico Bambino Gesù, Rome, Italy
12Department of Pediatric Hematology/Oncology, Cell and Gene Therapy, IRCCS Bambino Gesù Children's Hospital, Rome, Lazio, Italy
13M. TETTAMANTI RESEARCH INSTITUTE, MONZA, Italy
14SAPIENZA UNIVERSITY OF ROME, ROME, ITA
15Catholic University of the Sacred Heart, Rome, Italy

Guido Ghilardi, MD1,2,3*, Yong Gu Lee, PhD1,2,3,4, Patrizia Porazzi, PhD1,2,3*, Ivan Cohen, PhD1,2,3*, Luca Paruzzo, MD1,2,3,5*, Ositadimma H Ugwuanyi1,2,3*, Raymone Pajarillo, MS1,2,3*, Yunlin Zhang, MS1,2,3*, Puneeth Guruprasad, BS1,2,3*, Ruchi P. Patel, MS1,2,3, Elise A. Chong, MD1,3, Sunita Dwivedy Nasta, MD1,3, Stefan K. Barta, MD1,3, Alfred L. Garfall2,3*, Daniel J. Landsburg, MD1,3, Sam Sadigh6*, Mariusz Wasik6,7*, Jakub Svoboda, MD1,3, Siddharth Bhattacharyya, MD6*, Stephen J. Schuster, MD1,2,3 and Marco Ruella, MD1,2,3

1Lymphoma Program, University of Pennsylvania, Abramson Cancer Center, Philadelphia, PA
2Center for Cellular Immunotherapies, University of Pennsylvania School of Medicine, Philadelphia, PA
3Division of Hematology-Oncology, University of Pennsylvania School of Medicine, Philadelphia, PA
4College of Pharmacy and Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan, Korea, Republic of (South)
5Department of Oncology, University of Turin, Turin, Italy
6Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA
7Department of Pathology, Fox Chase Cancer Center, Philadelphia, PA

Jyoti Rana, PhD1*, Derek VanDyke2*, Maite Munoz1*, Sandeep RP Kumar, PhD1*, Miguel Gonzales1*, Jamie Spangler2,3* and Moanaro Biswas1

1Department of Pediatrics, IUPUI, Indianapolis, IN
2Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore
3Department of Biomedical Engineering, Johns Hopkins University, Baltimore

Sarah E. Moore, BS1,2, Jaquelyn T. Zoine, PhD2, Jeremy Chase Crawford, PhD3*, Deanna Langfitt, PhD2*, Juan M. Barajas, PhD4, Sherif Abdelhamed, PhD4, Ilaria Iacobucci, PhD4, Dalia Haydar, PhD2*, Giedre Krenciute, PhD2*, Charles G. Mullighan, MBBS, MD4, Jeffery M. Klco, MD, PhD4, Stephen Gottschalk, MD2, Paul G. Thomas, PhD3* and Mireya Paulina Velasquez, MD2

1St. Jude Graduate School of Biomedical Sciences, Memphis, TN
2Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TN
3Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN
4Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN

Zhuoxiao Cao*, Cuiqing Yang*, Yifang Wang*, Chao Wang*, Qingyang Wang*, Gang Ye, Tingting Liu*, Qin Wang*, Huanyu Wang*, Yanxue Gong*, Biye Wang* and Fuwei Jiang*

Shanghai Simnova Biotechnology Co., Ltd., Shanghai, China

Lorena Pérez-Amill, PhD1,2,3*, Mercedes Armand-Ugon, PhD1,2,3*, Sergio Peña1,2,3*, Maria Val Casals, PhD1,2,3*, Claudio Santos, PhD3*, Gerard Frigola, MD4*, Alfredo Minguela, PhD5*, Àlex Bataller Torralba, MD, PhD6,7*, Berta Casanovas, MSc2,8*, José Álamo, MD7*, Mireia Uribe, PhD2,8*, Diego Sánchez-Martínez, PhD6*, Néstor Tirado, MSc6*, Clara Bueno, PhD6*, Paola Alejandra Romecín, PhD6*, Pablo Menéndez, PhD6*, Antonio Martínez, MD, PhD9*, Montserrat Rovira, MD, PhD7,8,10*, Jordi Esteve, MD, PhD7,8,10*, Álvaro Urbano-Ispizua, MD, PhD6,7,8,10, Julio Delgado, MD, PhD7,8,10*, Manel Juan, MD, PhD2,8,10* and Nela Klein-González, MD, PhD1,2*

1Fundació Clínic per a la Recerca Biomèdica (FCRB), Barcelona, Spain
2Department of Immunology, Hospital Clínic of Barcelona, Barcelona, Spain
3Gyala Therapeutics S.L., Barcelona, Spain
4Hematopathology Section, Pathology Department, Hospital Clínic of Barcelona, Barcelona, Spain
5Department of Immunology, Hospital Clínico Universitario Virgen de la Arrixaca (HCUVA), Murcia, ESP
6Josep Carreras Leukemia Research Institute, School of Medicine, University of Barcelona, Barcelona, Spain
7Department of Hematology, Hospital Clínic of Barcelona, Barcelona, Spain
8Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
9Department of Pathology, Hospital Clínic of Barcelona, Barcelona, Spain
10University of Barcelona, Barcelona, Spain

Anson Snow, MD1, Lin Lin, PhD2*, Sally A. Hunsucker, PhD3*, Ying Wang, PhD4*, Rihe Liu, PhD4* and Paul M. Armistead, MD, PhD1*

1Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC
2Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill
3Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC
4UNC Eshelman School of Pharmacy, Chapel Hill

Jianghua Wu1,2*, Lu Tang1,2*, Mengyi Du1,2*, Chenggong Li1,3*, Haiming Kou1,2*, Huiwen Jiang1,3*, Wenjing Luo1,2*, Yinqiang Zhang1,2*, Zhongpei Huang1,3*, Danying Liao1,3*, Wei Xiong1,3*, Heng Mei1,2* and Yu Hu1,3*

1Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
2Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease, Wuhan, China
3Hubei clinical medical center of cell therapy for neoplastic disease, Wuhan, China

Mireia Bachiller1*, Cèlia Dobaño-López, MSc1*, Alba Rodríguez-García, PhD1*, Joan Castellsagué, PhD1*, Marta Gimenez-Alejandre, PhD1*, Asier Antoñana-Vildosola2*, Beatriz Martin-Antonio, PhD3*, Julio Delgado, MD, PhD4*, Patricia Pérez-Galán, PhD1*, Manel Juan, MD, PhD5*, Álvaro Urbano-Ispizua, MD, PhD1,4 and Sonia Guedan, PhD1*

1Department of Hematology and Oncology, Institut d’Investigacions Biomediques Agusti Pi i Sunyer (IDIBAPS), Barcelona, 08036, Spain, Barcelona, Spain
2Cancer Immunology and Immunotherapy Lab, CICbioGUNE, Vizcaya, Spain
3Instituto de Investigación Sanitaria/Fundación Jiménez Diaz, Madrid, Spain
4Department of Hematology, Hospital Clínic of Barcelona, Barcelona, Spain
5Department of Immunology, Hospital Clínic of Barcelona, Barcelona, Spain

Rina M Mbofung, PhD1*, Xingyue Zong, PhD2*, Erika Varady, PhD1*, Alan M Williams, PhD1*, Ken L Hayama, PhD1*, Yijia Pan, PhD1*, Sushil Devkota, PhD1*, Brian Groff, BS1*, Miguel Meza, BS1*, Thomas Dailey, BS1*, Tom Lee, PhD1*, Lilly Wong, PhD2*, Sarah Cooley, MD2, Ryan Bjordahl3*, Jode P Goodridge2* and Bahram Valamehr2

1Fate Therapeutics Inc., San Diego, CA
2Fate Therapeutics, Inc., San Diego, CA
3Fate Therapeutics, San Diego, CA

Yuelin Kong*, Manuel Fierro*, Somayeh Pouyanfard* and Dan S Kaufman, MD, PhD

Department of Medicine, Division of Regenerative Medicine, University of California San Diego, La Jolla, CA

Jun Yan, PhD1*, Ze Tian, PhD1*, Chunhua Shi, PhD1*, Mao Zhang, MPH2*, Pariya Sukhumalchandra, BS2*, Guojan Yang, MD1*, Qing Edward Chang, MD1*, Junping You, MD, PHD1*, Meng Cui, MD1*, Qing Shi, PHD1*, Anne Philip, PhD2*, Na Qiao, PhD2*, Anna Sergeeva, PhD2*, Lisa St John, PhD2*, Hong He, MD, PhD2*, Dongxing Zha, PhD1*, Jeffrey J. Molldrem, MD2 and Gheath Alatrash, PhD, DO3,4

1Oncology Research for Biologics and Immunotherapy Translation (ORBIT), The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Hematopoietic Biology & Malignancy, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Stem Cell Transplantation & Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
4MD Anderson Cancer Center, Houston, TX

William C Temple, MD1,2, Gianina Wicaksono3*, Akul Naik3*, Adila Izgutdina, MD3*, Matthew A Nix, PhD3*, Elizabeth Young, MD1*, Paul Phojanakong4*, Juan Antonio Camara Serrano, PhD, DVM4*, Veronica Steri, PhD4*, Fernando Salangsang4* and Arun P Wiita, MD, PhD5

1Department of Pediatrics, Division of Hematology/Oncology, UCSF Benioff Children's Hospital, University of California San Francisco, San Francisco, CA
2Department of Pediatrics, Division of Allergy, Immunology, and Bone Marrow Transplantation, UCSF Benioff Children's Hospital, University of California San Francisco, San Francisco, CA
3Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA
4Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA
5Department of Laboratory Medicine, UCSF, San Francisco, CA

Lauren Scherer, MD1, Candise Tat, B.S.2*, Tim Sauer, MD3*, Haruko Tashiro, MD, PhD4*, Swati Naik, MBBS5, Mireya Paulina Velasquez, MD6, Stephen Gottschalk, MD6, Cliona M. Rooney, PhD7*, Malcolm K. Brenner, MD, PhD7* and Bilal Omer, MD8

1Baylor College of Medicine, Houston, TX
2Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX
3Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany
4Department of Hematology/Oncology, Teikyo University School of Medicine, Tokyo, Japan
5St Jude Children's Research Hospital, Memphis, TN
6Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TN
7Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital, Houston Methodist Hospital, Houston, TX
8Center for Cell and Gene Therapy / Department of Pediatrics, Baylor College of Medicine, Houston, TX

Taylor Mandeville, BA1,2,3*, Cory Mavis, BSc, MSc2*, Juan Gu, PhD, MD4*, Noah Lemoine, BS4*, Kevin Bowman5*, Scott Olejniczak, Ph.D.6*, Prasenjit Dey, PhD1*, Gyorgy Paragh, MD, PhD2* and Francisco Hernandez-Ilizaliturri, MD1,7

1Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY
2Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY
3University at Buffalo, Roswell Park Comprehensive Cancer Center Graduate Division, Buffalo, NY
4Roswell Park Comprehensive Cancer Center, Buffalo, NY
5Roswell Park Comprehensive Cancer center, Buffalo
6Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY
7Department of Medical Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY

Sergio Rutella, MD, PhD, FRCPath, FRSB1, Amanda F. Cashen, MD2, John Muth, MS3*, Mary Elizabeth Mathyer, PhD3*, Alun James Carter, PhD3*, Brunda Tumala, PhD3*, Laura Arthur, PhD3*, Kristann Magee3*, Paula Comune Pennacchi, PhD4*, Julian Gorrochategui4*, Vincent Petit, PhD5*, Daniel Primo, PhD6*, Dominique Blanchard, PhD5*, Michael Kiebish, PhD7*, Nupur Bhatnagar, PhD5*, David Boocock, PhD1*, Jayakumar Vadakekolathu, PhD1*, Matthew L Cooper, PhD3, Melissa M. Berrien-Elliott, PhD2, Jan K Davidson-Moncada, MD, PhD, MSc3 and Todd A. Fehniger, MD, PhD8

1John van Geest Cancer Research Centre, Nottingham Trent University, Nottingham, United Kingdom
2Department of Medicine, Washington University School of Medicine, Saint Louis, MO
3Wugen, St. Louis, MO
4Vivia Biotech, Madrid, Spain
5Metafora Biosystems, Paris, France
6Vivia Biotech, Tres Cantos, Madrid, Spain
7Berg Health, Framingham, MA
8Division of Oncology, Washington University School of Medicine, St. Louis, MO

Zhaoqi Chen*, Yang Lu*, Yingxi Xu*, Shaowei Qiu, MD*, Runxia Gu*, Haiyan Xing, MS*, Kejing Tang, BS*, Zheng Tian*, Qing Rao, MS*, Dongsheng Xiong*, Min Wang* and Jianxiang Wang, MD

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China

Franziska Blaeschke, MD, PhD1,2, Yan Yi Chen1,2*, Ryan Apathy1,2*, Zhongmei Li1,2*, Cody T. Mowery1,2*, William A. Nyberg, PhD1,2*, Angela To1,2*, Ruby Yu, PhD1,2*, Raymund Bueno, PhD3*, Min Cheol Kim3*, Ralf Schmidt, MD1,2*, Daniel B. Goodman, PhD1,2,4,5*, Tobias Feuchtinger, MD6,7,8, Justin Eyquem, PhD9,10,11, Chun Jimmie Ye, PhD3,12,13,14*, Eric Shifrut, PhD1,2*, Theodore L. Roth, MD PhD1,15* and Alexander Marson, MD PhD2,3,4,5,10,16,17,18*

1Department of Medicine, University of California, San Francisco, San Francisco
2Gladstone-UCSF Institute of Genomic Immunology, San Francisco
3Institute for Human Genetics (IHG), University of California, San Francisco, San Francisco
4Diabetes Center, University of California, San Francisco, San Francisco
5Parker Institute for Cancer Immunotherapy, University of California, San Francisco, San Francisco
6Department Pediatric Hematology, Oncology and Stem Cell Transplantation, Dr. von Hauner Children’s Hospital, University Hospital, LMU Munich, Munich, Germany
7German Cancer Consortium (DKTK), partner site Munich, Munich, Germany
8National Center for Infection Research (DZIF), Munich, Germany
9Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA
10Department of Medicine, University of California, San Francisco, San Francisco, CA
11Parker Institute for Cancer Immunotherapy, University of California, San Francisco, San Francisco, CA
12Institute for Computational Health Sciences, University of California, San Francisco, San Francisco
13Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco
14Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco
15Department of Pathology, Stanford University, Stanford
16Department of Microbiology and Immunology, University of California, San Francisco, San Francisco
17Innovative Genomics Institute, University of California, Berkeley, Berkeley
18UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco

Davide Bernareggi, Ph.D.1*, Jiyoung Yun, MS1*, Benjamin Goldenson, MD, PhD2 and Dan S Kaufman, MD, PhD3

1UC San Diego, La Jolla, CA
2Department of Medicine, Division of Regenerative Medicine, University of California San Diego, La Jolla, CA
3University of California – San Diego, La Jolla, CA

Yukang Huang, PhD*, Yunfan Chen*, Junjie Shen, PhD*, Yanmin Xu, PhD*, Yanan Qi*, Zhi Yang, PhD*, Qianzhen Zhang*, Jun Chen*, Wenxu Zhao*, Juan Hong*, Jingwen Hu*, Liurong Jiao*, Qiushuang Zhu*, Linling Wang*, Yongchun Zhao*, Xia Huang*, Lei Qin*, Ruina Yao*, Depeng Dai*, Yunyan Li*, Meiling Wang* and Cheng Qian, MD*

Chongqing Precision Biotech Co., Ltd., Chongqing, China

Benoit Tessoulin, MD1,2*, Audrey Grain, MD3*, Jocelyn Ollier1*, Thomas Gastinne, MD2*, Viviane Dubruille, MD2*, Béatrice Mahé, MD2*, Nicolas Blin, MD2*, Anne Lok, MD2*, Sophie Vantyghem, MD2*, Clara Sortais, MD2*, Cyrille Touzeau, MD, PhD1,2,4*, Philippe Moreau, MD1,2,4*, Steven Le Gouill, MD, PhD1,2,5, Patrice Chevallier, MD1,2 and Beatrice Clemenceau, PhD1*

1CRCI2NA, Integrated Research Center in Immunology and Oncology, Nantes University, Nantes, France
2Hematology Department, Nantes University Hospital, Nantes, France
3Pediatric Hematology Department, Nantes University Hospital, Nantes, AL, France
4Site de Recherche Intégrée sur le Cancer (SIRIC), Imaging and Longitudinal Investigations to Ameliorate Decision-making (ILIAD), INCA-DGOS-Inserm 12558, Nantes, France
5Institut Curie Comprehensive Cancer Center, Paris, France

Ryan Stadel1*, Ruifu Liu2*, Yosef Landesman, PhD3*, David Wald, PhD, MD4,5*, Smitha Hosahalli Vasanna, MD, MBBS6 and Marcos J.G. de Lima, MD7

1CuronBiotech Inc., cleveland, OH
2Case Western Reserve University, Cleveland
3Karyopharm Therapeutics Inc., Newton, MA
4Case Western Reserve University, Cleveland, OH
5Curonbiotech, Cleveland
6Rainbow Babies and Childrens Hospital, Cleveland, OH
7Blood and Marrow and Cellular Therapy Program, Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH

Katherine D Cummins, PhD, BMBS1, Arjun Gupta1*, Ofrat Beyar-Katz, MD2*, Ye Li3*, Paramita Chatterjee3*, Linda Kippner3*, Olga Shestova, PhD4*, Monika A Eiva1*, January Salas-Mckee4*, Carolyn Yeago3*, Krishnendu Roy5* and Saar Gill, MD, PhD6,7

1Center for Cellular Immunotherapies (CCI), University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA
2BMT Unit, Tel Aviv (Sourasky) Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel, Tel Aviv, Israel
3Marcus Center for Therapeutic Cell Characterization and Manufacturing, Georgia Institute of Technology, Atlanta, GA
4Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
5Georgia Institute of Technology, Atlanta, GA
6Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
7Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA

Gina Chu, Ph.D1*, Kun-Yu Teng, Ph.D1*, Lisa Guerrettaz, Ph.D1*, Rodrigo Fernades Da Silva, Ph.D1*, Salvatore Rotondo, MS1*, Claudia Palomino La Torre, BS1*, Amanda Conerty, BS, (CLS) ASCP2*, Peter Flynn, PhD2*, Anita Seto, Ph.D1*, Heather Raymon, PhD2* and Srinivas Somanchi, PhD1*

1Artiva Biotherapeutics, San Diego, CA
2Artiva Biotherapeutics, Inc., San Diego, CA

Kai Rejeski, MD1, Viktoria Blumenberg, MD1, Simon KG Forsberg, PhD2*, Agnese Petrera, PhD3*, Niklas Mueller, MD, PhD1*, Friederike Hildebrandt, MD1*, Lisa Frölich1*, Philipp Karschnia, MD4*, Christian Schmidt, MD1*, Martin Dreyling, MD1, Michael von Bergwelt, Prof. Dr.1*, Marion Subklewe, MD5 and Veit L Buecklein, MD1*

1Department of Medicine III, University Hospital, LMU Munich, Munich, Germany
2Data Science Team, Olink Proteomics, Uppsala, Sweden
3Metabolomics and Proteomics Core Facility, Helmholtz Zentrum Munich – German Research Center for Environmental Health, Munich, Germany
4Department of Neurosurgery, University Hospital, LMU Munich, Munich, Germany
5Department of Medicine III (Hematology/Oncology), LMU University Hospital Munich, Muenchen, Germany

Caroline Smith, MD1, Ryan Huang2*, Jingjing Xie, PhD2*, Xiaoye Liu, PhD2*, Yubo He2*, Kathleen Ludwig, MD3*, Laura Klesse, MD, PhD3*, Chengcheng Zhang, PhD2* and Samuel John, MD1

1Division of Pediatric Hematology- Oncology, University of Texas Southwestern Medical Center, Dallas, TX
2Dept. of Physiology, University of Texas Southwestern Medical Center, Dallas
3Division of Pediatric Hematology- Oncology, University of Texas Southwestern Medical Center, Dallas

Arnold Kloos, PhD1*, Christos Georgiadis, PhD2*, Annie Etuk, PhD2*, Soragia Athina Gkazi, PhD2*, Farhatullah Syed, PhD3*, Toni Braybrook2*, Hong Zhan, MD, PhD2*, Renuka Kadirkamanathan2*, Nadine Kattre1*, Kerstin Görlich1*, Thomas Fangmann1*, Axel Schambach, MD, PhD4*, Martin G. Sauer, MD5, Michael Heuser, MD1 and Waseem Qasim, MBBS, PhD2*

1Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
2Molecular and Cellular Immunology Unit, UCL Great Ormond Street Institute of Child Health, London, United Kingdom
3King Faisal Specialist Hospital & Research Centre (KFSH&RC), Riyadh, Saudi Arabia
4Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany
5Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany

Ana Belén Moreno-Castaño, MD, PhD Student1*, Sara Fernandez, MD2*, Marta Palomo, PhD3*, Julia Martinez-Sanchez, PhD Student4*, Alex Ramos, PhD Student5*, Patricia Molina, Technician6*, Marc Pino, Technician7*, Valentín Ortiz-Maldonado, MD8*, Julio Delgado, MD, PhD9,10,11,12*, Carlos Fernández De Larrea, MD, PhD13,14*, Álvaro Urbano-Ispizua, MD, PhD9,10,12,15, Gines Escolar, MD, Ph16*, Enric Carreras, MD, PhD17*, Francesc Fernández-Avilés18*, Pedro Castro, MD, PhD19* and Maribel Diaz-Ricart, PhD1*

1Hematopathology, Pathology Department, CDB, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain
2Department of Critical Care Medicine, Hospital Clínic of Barcelona, Barcelona, Spain
3Hematopathology, Pathology Department, Centre Diagnòstic Biomèdic (CDB), Hospital Clínic, Barcelona, Spain, Barcelona, Spain
4Josep Carreras Leukaemia Research Institute, Hospital Clínic of Barcelona, University of Barcelona, Barcelona Endothelium Team (BET), Barcelona, Spain, Barcelona, Spain
5Josep Carreras Leukaemia Research Institute (Campus Clinic). Barcelona, Barcelona, Spain
6Hematopathology, Pathology Department, CDB, Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona, Spain., Barcelona, Spain
7Hematopathology, Pathology Department, CDB. IDIBAPS. Hospital Clinic de Barcelona., Barcelona, Spain
8Hematology Department, Institut Clínic de Malalties Hemato-Oncològiques (ICMHO), Hospital Clínic, Barcelona. Institut d’Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain
9Department of Hematology, Hospital Clínic of Barcelona, Barcelona, Spain
10University of Barcelona, Barcelona, Spain
11Hospital Clínic of Barcelona, Barcelona, Spain
12Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
13Hematology Department, Institut Clínic de Malalties Hemato-Oncològiques (ICMHO), Hospital Clínic, Barcelona., Barcelona, Spain
14Amyloidosis and Myeloma Unit, Hospital Clínic, Barcelona, Institut d’Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain
15Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Spain
16Hematopathology, Pathology Department, CDB, Hospital Clinic, Barcelona, ESP
17Fundació i Institut de Recerca Josep Carreras contra la leucèmia (Campus Clínic), Barcelona, Spain
18Hematology Department, Institut Clínic de Malalties Hemato-Oncològiques (ICMHO), Hospital Clínic, Barcelona, Barcelona, Spain
19Department of Critical Care Medicine, Hospital Clínic of Barcelona, IDIBAPS, University of Barcelona, Barcelona Endothelium Team (BET), Barcelona, Spain, Barcelona, Spain

Eigen Peralta, PhD1*, Dan Lu, PhD1*, Mark Landon1*, Hui-yi Chu, PhD1*, Soo Park1*, Masanao Tsuda1*, Trevor Zarecki1*, Elena Demeester1*, Matthew Denholtz, PhD1*, Amit Mehta, PhD1*, Earl Avramis, BS1*, Philip Chu1*, Jeffrey Chen1*, Eric Sung, MS1*, Alec Witty, PhD1*, Tom Lee, PhD2* and Bahram Valamehr1

1Fate Therapeutics, Inc., San Diego, CA
2Fate Therapeutics Inc., San Diego, CA

Shannon Oda, PhD1,2, Edison Chiu3*, Aitong Ruan4*, Emily Mather5*, Sofia Nguyen5* and Monica Hu5*

1Ben Towne Center, Seattle Children's Research Institute, Seattle, WA
2Department of Pediatrics, University of Washington, Seattle
3Seattle Children's Research Institute, Seattle, WA
4Seattle Children's Research Institute, Seattle
5University of Washington, Seattle, WA

*signifies non-member of ASH